Does PALBOCICLIB Cause Hyperhidrosis? 376 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 376 reports of Hyperhidrosis have been filed in association with PALBOCICLIB (Ibrance). This represents 0.4% of all adverse event reports for PALBOCICLIB.
376
Reports of Hyperhidrosis with PALBOCICLIB
0.4%
of all PALBOCICLIB reports
16
Deaths
70
Hospitalizations
How Dangerous Is Hyperhidrosis From PALBOCICLIB?
Of the 376 reports, 16 (4.3%) resulted in death, 70 (18.6%) required hospitalization, and 9 (2.4%) were considered life-threatening.
Is Hyperhidrosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALBOCICLIB. However, 376 reports have been filed with the FAERS database.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause Hyperhidrosis?
DULOXETINE (4,101)
ADALIMUMAB (2,745)
SODIUM (2,444)
VENLAFAXINE (1,932)
LEVOTHYROXINE (1,856)
ACETAMINOPHEN (1,578)
ETANERCEPT (1,521)
MORPHINE (1,438)
GABAPENTIN (1,408)
PREGABALIN (1,385)
Which PALBOCICLIB Alternatives Have Lower Hyperhidrosis Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID